×

Message

EU e-Privacy Directive

This website uses cookies to manage authentication, navigation, and other functions. By using our website, you agree that we can place these types of cookies on your device.

View e-Privacy Directive Documents

You have declined cookies. This decision can be reversed.

THERAPEUTIC SUBSTANCES

Vitamin C in Stem Cell Reprogramming and Cancer.

Written by CYBERMED LIFE NEWS
Abstract Title:

Vitamin C in Stem Cell Reprogramming and Cancer.

Abstract Source:

Trends Cell Biol. 2018 Apr 30. Epub 2018 Apr 30. PMID: 29724526

Abstract Author(s):

Luisa Cimmino, Benjamin G Neel, Iannis Aifantis

Article Affiliation:

Luisa Cimmino

Abstract:

Vitamin C is an essential dietary requirement for humans. In addition to its known role as an antioxidant, vitamin C is a cofactor for Fe- andα-ketoglutarate-dependent dioxygenases (Fe/α-KGDDs) which comprise a large number of diverse enzymes, including collagen prolyl hydroxylases and epigenetic regulators of histone and DNA methylation. Vitamin C can modulate embryonic stem cell (ESC) function, enhance reprogramming of fibroblasts to induced pluripotent stem cells (iPSCs), andhinder the aberrant self-renewal of hematopoietic stem cells (HSCs) through its ability to enhance the activity of either Jumonji C (JmjC) domain-containing histone demethylases or ten-eleven translocation (TET) DNA hydroxylases. Given that epigenetic dysregulation is a known driver of malignancy, vitamin C may play a novel role as an epigenetic anticancer agent.